New Antibiotics for Pneumonia
Author:
Funder
Achaogen
Angelini
Astellas
AstraZeneca
Bayer
Basilea
Cidara
Gilead
Menarini
MSD
Paratek
Pfizer
Roche
The Medicine Company
Shionogi
Tetraphase
VenatoRx
Vifor
Publisher
Elsevier BV
Subject
Pulmonary and Respiratory Medicine,Pulmonary and Respiratory Medicine
Reference113 articles.
1. The intensive care medicine research agenda on multidrug-resistant bacteria, antibiotics, and stewardship;Kollef;Intensive Care Med,2017
2. Treatment of Gram-negative pneumonia in the critical care setting: is the beta-lactam antibiotic backbone broken beyond repair?;Bassetti;Crit Care,2016
3. Epidemiology and pre- dictors of multidrug-resistant community-acquired and healthcare-associated pneumonia;Gross;Antimicrob Agents Chemother,2014
4. Clinical predictors and microbiology of ventilator-associated pneumonia in the intensive care unit: a retrospective analysis in six Italian hospitals;Delle Rose;Eur J Clin Microbiol Infect Dis,2016
5. Antimicrobial stewardship opportunities in critically ill patients with gram-negative lower respiratory tract infections: a multicenter cross-sectional analysis;Claeys;Infect Dis Ther,2018
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Efficacy of cefiderocol- vs colistin-containing regimen for treatment of bacteraemic ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii in patients with COVID-19;International Journal of Antimicrobial Agents;2023-07
2. Treatment of MDR Gram-Negative Bacteria Infections: Ongoing and Prospective;Journal of Pure and Applied Microbiology;2022-08-27
3. Current and future perspectives in the treatment of multidrug-resistant Gram-negative infections;Journal of Antimicrobial Chemotherapy;2021-11-01
4. His-Rich Peptides, Gly- and His-Rich Peptides: Functionally Versatile Compounds with Potential Multi-Purpose Applications;International Journal of Peptide Research and Therapeutics;2021-10-21
5. Editorial: Spotlight on the Relationship Between Sepsis and Infection: From Mechanisms to Therapy;Frontiers in Medicine;2021-08-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3